Chloroquine phosphate; primaquine phosphate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for chloroquine phosphate; primaquine phosphate and what is the scope of patent protection?
Chloroquine phosphate; primaquine phosphate
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for chloroquine phosphate; primaquine phosphate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 18 |
| DailyMed Link: | chloroquine phosphate; primaquine phosphate at DailyMed |
Recent Clinical Trials for chloroquine phosphate; primaquine phosphate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Pan American Health Organization | Phase 2/Phase 3 |
| University of California, San Francisco | Phase 2/Phase 3 |
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | Phase 2 |
See all chloroquine phosphate; primaquine phosphate clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for chloroquine phosphate; primaquine phosphate
US Patents and Regulatory Information for chloroquine phosphate; primaquine phosphate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE | chloroquine phosphate; primaquine phosphate | TABLET;ORAL | 014860-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
